Ruxolitinib Synergizes With Dexamethasone for the Treatment of T-cell Acute Lymphoblastic Leukemia

Ruxolitinib Synergizes With Dexamethasone for the Treatment of T-cell Acute Lymphoblastic Leukemia

Bibliographic Details
Main Authors:	Delphine Verbeke, Olga Gielen, Kris Jacobs, Nancy Boeckx, Kim De Keersmaecker, Johan Maertens, Anne Uyttebroeck, Heidi Segers, Jan Cools
Format:	Article
Language:	English
Published:	Wiley 2019-12-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/HS9.0000000000000310

Similar Items

PSEN1-selective gamma-secretase inhibition in combination with kinase or XPO-1 inhibitors effectively targets T cell acute lymphoblastic leukemia
by: Inge Govaerts, et al.
Published: (2021-06-01)

Monitoring of Leukemia Clones in B-cell Acute Lymphoblastic Leukemia at Diagnosis and During Treatment by Single-cell DNA Amplicon Sequencing
by: Sarah Meyers, et al.
Published: (2022-04-01)

P348: MRK-560 AND DEXAMETHASONE ARE SYNERGISTIC IN THE TREATMENT OF T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
by: C. Vandersmissen, et al.
Published: (2022-06-01)

BCR-ABL1 positive B-ALL can undergo T-cell lineage shift to become CD19 negative T-ALL
by: Jolien De Bie, et al.
Published: (2018-06-01)

Age- and Intravenous Methotrexate-Associated Leukoencephalopathy and Its Neurological Impact in Pediatric Patients with Lymphoblastic Leukemia
by: Ilona Rijmenams, et al.
Published: (2021-04-01)

Synergism Through WEE1 and CHK1 Inhibition in Acute Lymphoblastic Leukemia
by: Andrea Ghelli Luserna Di Rorà, et al.
Published: (2019-10-01)

Mechanisms underlying transcription factor deregulation in acute lymphoblastic leukemia
by: Jan Cools
Published: (2018-06-01)

Comprehensive analysis of transcriptome variation uncovers known and novel driver events in T-cell acute lymphoblastic leukemia.
by: Zeynep Kalender Atak, et al.
Published: (2013-01-01)

Case report: Ruxolitinib plus dexamethasone as first-line therapy in haemophagocytic lymphohistiocytosis
by: Lin Zhao, et al.
Published: (2023-03-01)

Antileukemic Efficacy of Continuous vs Discontinuous Dexamethasone in Murine Models of Acute Lymphoblastic Leukemia.
by: Laura B Ramsey, et al.
Published: (2015-01-01)

Ruxolitinib versus dexamethasone in hospitalized adults with COVID-19: multicenter matched cohort study
by: O. V. Stanevich, et al.
Published: (2021-12-01)

Myb overexpression synergizes with the loss of Pten and is a dependency factor and therapeutic target in T‐cell lymphoblastic leukemia
by: André Almeida, et al.
Published: (2024-03-01)

Synergism between the mTOR inhibitor rapamycin and FAK down-regulation in the treatment of acute lymphoblastic leukemia
by: Pei-Jie Shi, et al.
Published: (2016-02-01)

EML1–ABL1 Is Activated by Coiled-Coil-Mediated Oligomerization and Induces T-Cell Acute Lymphoblastic Leukemia or Myeloproliferative Disease in a Mouse Bone Marrow Transplant Model
by: Marlies Vanden Bempt, et al.
Published: (2018-04-01)

Sequential allogeneic transplantation and ruxolitinib maintenance for a synchronous PCM1‐JAK2 positive myeloid sarcoma and acute B‐lymphoblastic leukemia
by: Giuliana Rizzuto, et al.
Published: (2022-01-01)

Acute Activation of Metabolic Syndrome Components in Pediatric Acute Lymphoblastic Leukemia Patients Treated with Dexamethasone.
by: Lidewij T Warris, et al.
Published: (2016-01-01)

Identification of RNPC3 as a novel JAK2 fusion partner gene in B‐acute lymphoblastic leukemia refractory to combination therapy including ruxolitinib
by: Xue Chen, et al.
Published: (2020-03-01)

Honokiol induces apoptosis and autophagy in dexamethasone-resistant T-acute lymphoblastic leukemia CEM-C1 cells
by: Yang Liu, et al.
Published: (2024-12-01)

Testicular relapse of acute lymphoblastic leukemia
by: Alexandra Carolan, et al.
Published: (2023-09-01)

Paradoxical activation of chronic lymphocytic leukemia cells by ruxolitinib in vitro and in vivo
by: David E. Spaner, et al.
Published: (2023-04-01)

Dexamethasone-Induced Sarcopenia and Physical Frailty in Children With Acute Lymphoblastic Leukemia: Protocol for a Prospective Cohort Study
by: Emma Jacobine Verwaaijen, et al.
Published: (2022-04-01)

Knockdown of G1P3 inhibits cell proliferation and enhances the cytotoxicity of dexamethasone in acute lymphoblastic leukemia
by: Zou Liping, et al.
Published: (2022-02-01)

Venetoclax for Children and Adolescents with Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma
by: Amber Gibson, et al.
Published: (2021-12-01)

Icariin synergizes therapeutic effect of dexamethasone on adriamycin-induced nephrotic syndrome
by: Juan Lv, et al.
Published: (2023-01-01)

Mutant p53-reactivating compound APR-246 synergizes with asparaginase in inducing growth suppression in acute lymphoblastic leukemia cells
by: Sophia Ceder, et al.
Published: (2021-07-01)

Partial response to venetoclax and ruxolitinib combination in a case of refractory T-prolymphocytic leukemia
by: Joel Brothers, et al.
Published: (2023-12-01)

JAK3 mutations and HOXA9 expression are important cooperating events in T-cell acute lymphoblastic leukemia
by: Charles E. de Bock, et al.
Published: (2018-05-01)

A Novel Combination of Pterostilbene and Dexamethasone Enhances Anti-proliferation and Apoptosis Induction Properties in Lymphoblastic Leukemia Cell Line
by: Zahra Sourani, et al.
Published: (2020-10-01)

Acute lymphoblastic leukemia
by: Martin Schrappe
Published: (2018-06-01)

Acute lymphoblastic leukemia
by: Toljić Branka G., et al.
Published: (2023-01-01)

Correction: Mutant p53-reactivating compound APR-246 synergizes with asparaginase in inducing growth suppression in acute lymphoblastic leukemia cells
by: Sophia Ceder, et al.
Published: (2022-08-01)

An ensemble-acute lymphoblastic leukemia model for acute lymphoblastic leukemia image classification
by: Mei-Ling Huang, et al.
Published: (2024-01-01)

Defective migration and dysmorphology of neutrophil granulocytes in atypical chronic myeloid leukemia treated with ruxolitinib
by: Lea Bornemann, et al.
Published: (2020-07-01)

Ruxolitinib/nilotinib cotreatment inhibits leukemia-propagating cells in Philadelphia chromosome-positive ALL
by: Yuan Kong, et al.
Published: (2017-08-01)

Translatome analysis reveals altered serine and glycine metabolism in T-cell acute lymphoblastic leukemia cells
by: Kim R. Kampen, et al.
Published: (2019-06-01)

Synergism between IL7R and CXCR4 drives BCR-ABL induced transformation in Philadelphia chromosome-positive acute lymphoblastic leukemia
by: Hend Abdelrasoul, et al.
Published: (2020-06-01)

Acute lymphoblastic leukemia in children
by: M. A. Maschan, et al.
Published: (2022-11-01)

Childhood acute lymphoblastic leukemia
by: G. Mesera, et al.
Published: (2019-09-01)

Osteoporosis in Acute Lymphoblastic Leukemia
by: Lestry Fibriani, et al.
Published: (2019-09-01)

Acute lymphoblastic leukemia in adults
by: Josep-Maria Ribera
Published: (2011-06-01)